With the antipsychotic for 14 consecutive days to maintain therapeuticĪntipsychotic concentrations during initiation of therapy. Patients already stable on another oral antipsychotic (and known to tolerateĪripiprazole), after the first ABILIFY MAINTENA injection, continue treatment
Therapeutic aripiprazole concentrations during initiation of therapy. Oral aripiprazole (10 mg to 20 mg) for 14 consecutive days to achieve Due to the half-life of oral aripiprazole, it may take up to 2 weeksĪfter the first ABILIFY MAINTENA injection, administer Tolerability with oral aripiprazole prior to initiating treatment with ABILIFY Maintenance dose of ABILIFY MAINTENA is 400 mg monthly (no sooner than 26 daysįor patients who have never taken aripiprazole, establish DOSAGE AND ADMINISTRATION Dosage Overview For The Treatment Of SchizophreniaĪBILIFY MAINTENA is only to be administered by intramuscular Is indicated for the treatment of schizophrenia. redness, pain and swelling at the injection site.Inactive ingredients (per administered dose) for 400 mg and 300 mg strength products, respectively, include carboxymethyl cellulose sodium (16.64 mg and 12.48 mg), mannitol (83.2 mg and 62.4 mg), sodium phosphate monobasic monohydrate (1.48 mg and 1.11 mg) and sodium hydroxide (pH adjuster). The labeled strengths are calculated based on the anhydrous form (aripiprazole). The chemical structure is:ĪBILIFY MAINTENA (aripiprazole) is an extended-release injectable suspension available in 400-mg or 300-mg strength pre-filled dual chamber syringes and 400-mg or 300-mg strength vials. H 2O and its molecular weight is 466.40.The empirical formula is C 23H 27Cl 2N 3O 2 Aripiprazole monohydrate is 7- butoxy]-3,4 dihydrocarbostyril monohydrate. DESCRIPTIONĪripiprazole is an atypical antipsychotic which is present in ABILIFY MAINTENA as its monohydrate polymorphic form. ABILIFY MAINTENA is not approved for the treatment of patients with dementia-related psychosis. INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSISĮlderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. You may report side effects to FDA at 1-80. For more information, ask your doctor or pharmacist.Ĭall your doctor for medical advice about side effects. These are not all the possible side effects of Abilify Maintena. Tell the doctor if you have any side effect that bothers you or that does not go away. The most common side effects of Abilify Maintena include: Get medical help right away, if you have any of the symptoms listed above. swelling of the face, tongue or throat,.muscle stiffness, pain, tenderness or weakness,.uncontrolled movements (face, mouth, tongue, arms or legs),.What are the possible side effects of Abilify Maintena?Ībilify Maintena may cause serious side effects including: It is not known if Abilify Maintena is safe and effective in children younger than 6 years of age. Abilify Maintena may be used alone or with other medications.Ībilify Maintena belongs to a class of drugs called Antipsychotics, 2nd Generation Antimanic Agents.
Find Lowest Prices on What is Abilify Maintena and how is it used?Ībilify Maintena is a prescription medicine used to treat the symptoms of Schizophrenia, Bipolar Mania and Major Depressive Disorder.
0 kommentar(er)
